NUVL Q2 2025 Earnings — Nuvalent, Inc. Revenue & Financial Results | Market Cap Arena

NUVLNuvalent, Inc.

$8B

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$105M

Net Income

-$100M

EPS (Diluted)

$-1.39

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$77M

Free Cash Flow

-$77M

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$1.0B

Total Liabilities

$101M

Stockholders' Equity

$940M

Cash & Equivalents

$127M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$105M	-$65M	-60.5%
Net Income	-$100M	-$57M	-74.3%